Skip to main content

Hepatitis D Virus (HDV) Total Antibody

Test Code: 99202
Expand All Collapse All
Clinical and Procedure
Clinical Utility

Hepatitis D virus (HDV) is an incomplete RNA virus that requires the helper function of Hepatitis B virus (HBV) envelope proteins (HBSAg) to replicate. The presence of HDV antibodies indicates exposure to HDV, but does not distinguish acute or chronic HDV infection. Typically the disappearance of HDV antibodies is indicative of resolution of infection. The assay method is a competitive ELISA utilizing recombinant HDV antigen.


The HDV total antibody ELISA is a competitive immunoassay. Anti-HDV antibodies, if present, compete with HRP-conjugated polyclonal anti-HDV antibodies for recombinant HDV antigen adsorbed to the microtiter plate. This test was developed and its performance characteristics determined by Viracor Eurofins. It has not been cleared or approved by the U.S. Food and Drug Administration. Results should be used in conjunction with clinical findings, and should not form the sole basis for a diagnosis or treatment decision.

Turnaround Time

1-5 business days from receipt of specimen

Specimen Information
Specimen Type Order Code CPT Code NY Approved Volume Assay Range Special Instructions
serum 99202 86692 Yes

2 mL

Qualitative. (Negative/Equivocal/Positive)

  • Collect 4-5 mL whole blood in red top tube.
  • Centrifuge and transfer 2 mL serum to sterile, screw top tube.
  • Can be shipped at ambient or frozen temperature Monday through Friday.
  • Specimens shipped at ambient temperature must be received within 4 days of collection.

Qualitative. (Negative/Equivocal/Positive).


Ship Monday through Friday. Friday shipments must be labeled for Saturday delivery. All specimens must be labeled with patient's name and collection date. A Viracor Eurofins test requisition form must accompany each specimen. Multiple tests can be run on one specimen. Ship specimens FedEx Priority Overnight® to: Viracor Eurofins, 18000 W 99th St. Ste, #10, Lenexa, KS 66219.

Causes for Rejection

Specimens beyond their acceptable length of time from collection as listed in the specimen handling, or specimen types other than those listed. Hemolyzed and lipemic samples will be reported with a cautionary comment.


Specimens are approved for testing in New York only when indicated in the Specimen Information field above. The CPT codes provided are based on Viracor Eurofins' interpretation of the American Medical Association's Current Procedural Terminology (CPT) codes and are provided for informational purposes only. CPT coding is the sole responsibility of the billing party. Questions regarding coding should be addressed to your local Medicare carrier. Viracor Eurofins assumes no responsibility for billing errors due to reliance on the CPT codes illustrated in this material.

Back to top